Angina

In patients with angina with nonobstructive CAD, invasive testing increased the likelihood of an angina endotype diagnosis and improved treatment satisfaction compared with controls, but did not improve angina burden, researchers reported.

Compared with metallic drug-eluting stents, a first-generation everolimus-eluting bioresorbable vascular scaffold had similar 5-year rates of death, patient-oriented composite events, angina recurrence and quality of life, data show.

Increased change in fractional flow reserve at 3-month follow-up after PCI was moderately associated with less angina and improved quality of life, researchers reported.

In patients with stable angina, increased risk for stroke and mortality was positively correlated with higher consumption of milk and total dairy intake, researchers reported in the European Journal of Preventive Cardiology.

BOSTON — Quantitative flow ratio-guided decision-making improved outcomes in patients with angina or recent MI vs. a standard angiography-guided strategy, regardless of whether preplanned PCI was performed or not, a speaker reported.

Sex-specific differences in the performance of noninvasive testing for ischemic heart disease necessitate a sex-based diagnostic workup with a multimodality approach to better understand women’s chest pain symptoms, researchers reported.

Diltiazem vs. placebo for coronary vasomotor dysfunction in patients with angina and nonobstructive CAD.

WASHINGTON — Complete revascularization, as opposed to culprit lesion-only revascularization, was associated with better angina-related quality of life in patients with STEMI and multivessel CAD, a speaker reported.

WASHINGTON — In the first randomized trial of a therapy for treatment of patients with angina and nonobstructive CAD, diltiazem did not improve coronary vasomotor dysfunction compared with placebo.

Poor sleep health was associated with increased risk for experiencing CVD, according to data published in Scientific Reports.